Amphipathic Peptide Antibiotics with Potent Activity against Multidrug-Resistant Pathogens

The emergence and prevalence of multidrug-resistant (MDR) bacteria have posed a serious threat to public health. Of particular concern are methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) and <i>bla</i><sub>NDM</sub>, <i>mcr-1</i> and <i>...

Full description

Bibliographic Details
Main Authors: Jingru Shi, Chen Chen, Dejuan Wang, Ziwen Tong, Zhiqiang Wang, Yuan Liu
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/4/438
_version_ 1797540260059545600
author Jingru Shi
Chen Chen
Dejuan Wang
Ziwen Tong
Zhiqiang Wang
Yuan Liu
author_facet Jingru Shi
Chen Chen
Dejuan Wang
Ziwen Tong
Zhiqiang Wang
Yuan Liu
author_sort Jingru Shi
collection DOAJ
description The emergence and prevalence of multidrug-resistant (MDR) bacteria have posed a serious threat to public health. Of particular concern are methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) and <i>bla</i><sub>NDM</sub>, <i>mcr-1</i> and <i>tet</i>(X)-positive Gram-negative pathogens. The fact that few new antibiotics have been approved in recent years exacerbates this global crisis, thus, new alternatives are urgently needed. Antimicrobial peptides (AMPs) originated from host defense peptides with a wide range of sources and multiple functions, are less prone to achieve resistance. All these characteristics laid the foundation for AMPs to become potential antibiotic candidates. In this study, we revealed that peptide WW307 displayed potent antibacterial and bactericidal activity against MDR bacteria, including MRSA and Gram-negative bacteria carrying <i>bla</i><sub>NDM-5</sub>, <i>mcr-1</i> or <i>tet</i>(X4). In addition, WW307 exhibited great biofilm inhibition and eradication activity. Safety and stability experiments showed that WW307 had a strong resistance against various physiological conditions and displayed relatively low toxicity. Mechanistic experiments showed that WW307 resulted in membrane damage by selectively targeting bacterial membrane-specific components, including lipopolysaccharide (LPS), phosphatidylglycerol (PG), and cardiolipin (CL). Moreover, WW307 dissipated membrane potential and triggered the production of reactive oxygen species (ROS). Collectively, these results demonstrated that WW307 represents a promising candidate for combating MDR pathogens.
first_indexed 2024-03-10T12:57:33Z
format Article
id doaj.art-e44af635adb240ec8af45252b934df60
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T12:57:33Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-e44af635adb240ec8af45252b934df602023-11-21T11:48:08ZengMDPI AGPharmaceutics1999-49232021-03-0113443810.3390/pharmaceutics13040438Amphipathic Peptide Antibiotics with Potent Activity against Multidrug-Resistant PathogensJingru Shi0Chen Chen1Dejuan Wang2Ziwen Tong3Zhiqiang Wang4Yuan Liu5College of Veterinary Medicine, Yangzhou University, Yangzhou 225009, ChinaCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, ChinaCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, ChinaCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, ChinaCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, ChinaCollege of Veterinary Medicine, Yangzhou University, Yangzhou 225009, ChinaThe emergence and prevalence of multidrug-resistant (MDR) bacteria have posed a serious threat to public health. Of particular concern are methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) and <i>bla</i><sub>NDM</sub>, <i>mcr-1</i> and <i>tet</i>(X)-positive Gram-negative pathogens. The fact that few new antibiotics have been approved in recent years exacerbates this global crisis, thus, new alternatives are urgently needed. Antimicrobial peptides (AMPs) originated from host defense peptides with a wide range of sources and multiple functions, are less prone to achieve resistance. All these characteristics laid the foundation for AMPs to become potential antibiotic candidates. In this study, we revealed that peptide WW307 displayed potent antibacterial and bactericidal activity against MDR bacteria, including MRSA and Gram-negative bacteria carrying <i>bla</i><sub>NDM-5</sub>, <i>mcr-1</i> or <i>tet</i>(X4). In addition, WW307 exhibited great biofilm inhibition and eradication activity. Safety and stability experiments showed that WW307 had a strong resistance against various physiological conditions and displayed relatively low toxicity. Mechanistic experiments showed that WW307 resulted in membrane damage by selectively targeting bacterial membrane-specific components, including lipopolysaccharide (LPS), phosphatidylglycerol (PG), and cardiolipin (CL). Moreover, WW307 dissipated membrane potential and triggered the production of reactive oxygen species (ROS). Collectively, these results demonstrated that WW307 represents a promising candidate for combating MDR pathogens.https://www.mdpi.com/1999-4923/13/4/438antimicrobial peptideantibiotic resistancemultidrug-resistant bacteriamembrane damage
spellingShingle Jingru Shi
Chen Chen
Dejuan Wang
Ziwen Tong
Zhiqiang Wang
Yuan Liu
Amphipathic Peptide Antibiotics with Potent Activity against Multidrug-Resistant Pathogens
Pharmaceutics
antimicrobial peptide
antibiotic resistance
multidrug-resistant bacteria
membrane damage
title Amphipathic Peptide Antibiotics with Potent Activity against Multidrug-Resistant Pathogens
title_full Amphipathic Peptide Antibiotics with Potent Activity against Multidrug-Resistant Pathogens
title_fullStr Amphipathic Peptide Antibiotics with Potent Activity against Multidrug-Resistant Pathogens
title_full_unstemmed Amphipathic Peptide Antibiotics with Potent Activity against Multidrug-Resistant Pathogens
title_short Amphipathic Peptide Antibiotics with Potent Activity against Multidrug-Resistant Pathogens
title_sort amphipathic peptide antibiotics with potent activity against multidrug resistant pathogens
topic antimicrobial peptide
antibiotic resistance
multidrug-resistant bacteria
membrane damage
url https://www.mdpi.com/1999-4923/13/4/438
work_keys_str_mv AT jingrushi amphipathicpeptideantibioticswithpotentactivityagainstmultidrugresistantpathogens
AT chenchen amphipathicpeptideantibioticswithpotentactivityagainstmultidrugresistantpathogens
AT dejuanwang amphipathicpeptideantibioticswithpotentactivityagainstmultidrugresistantpathogens
AT ziwentong amphipathicpeptideantibioticswithpotentactivityagainstmultidrugresistantpathogens
AT zhiqiangwang amphipathicpeptideantibioticswithpotentactivityagainstmultidrugresistantpathogens
AT yuanliu amphipathicpeptideantibioticswithpotentactivityagainstmultidrugresistantpathogens